Company intelligence / Profile preview

NZYtech

Lisbon, Portugal

Ownership: Private
Employees: ~135
Development stage: Other

Overview

NZYtech supplies commercially validated research and diagnostic kits, high-performance enzymes, proteins, and nucleic acid reagents for molecular biology and analytics, serving global laboratories and biotech companies. They are not a clinical-stage therapeutics company and do not publish clinical results.

Modalities: EnzymeRecombinant proteinAssay kitOligonucleotide (for molecular services such as gene synthesis)Small molecule (for biochemical reagents)
Industry: Molecular Diagnostics

Partnerships

BiomolSanbioStratech

Beyond the preview

Go deeper on NZYtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NZYtech.

Explore the full profile